Cincinnati Children’s international collaborative to fund three pediatric medical device projects

A recently launched partnership between Cincinnati Children’s Hospital Medical Center and Ben-Gurion University in Israel is funding the research and development of three pediatric-specific medical devices.

The collaboration, which pairs the medical expertise of CCHMC physicians with the technical and engineering capabilities of BGU, started with nearly 80 unaddressed problems facing surgeons and physicians. After reviewing these ideas and proposed solutions, 10 projects underwent rigorous application cycles, thorough market analyses and review by internal and external stakeholders.

The initial three projects that will be funded—a smart sensing catheter, a surfactant-delivery device, and an image-guided needle insertion device—have potential to not only improve patient care and outcomes, but also reduce costs to the healthcare system.

“The pediatric market, especially with regard to medical devices, has historically been neglected primarily due to prohibitive development costs,” said Niki Robinson, assistant vice president of CCHMC’s Center for Technology Commercialization. “This initiative presents an unprecedented opportunity for early stage ideas to receive funding and move through a development plan backed by world-class physicians and engineers.”

The smart sensing catheter concept was developed by Richard Azizkhan, MD, surgeon-in-chief at CCHMC and the Lester W. Martin Chair of Pediatric Surgery, and Ibrahim Abdulhalim, professor of electro-optical engineering at BGU. The device provides immediate and continuous assessment of the metabolic and physiological profile of critically ill infants and small children. “Secondarily, this technology will reduce the need for repeated tests, thus reducing costs for the health system and society,” said Azizkhan.

The surfactant delivery device concept was developed by Jeffrey Whitsett, MD, co-director, Perinatal Institute and chief, section of neonatology, perinatal and pulmonary biology at CCHMC, and Joseph Kost, dean of the faculty of engineering sciences and professor of biomedical engineering at BGU. It consists of a delivery system for prolonged administration of surfactants to the lungs of premature babies using nanoparticles. Current procedures do not allow for the sustained release of proteins or other complex particles in the alveoli of infants or adults.

Daniel von Allmen, MD, director, Division of General and Thoracic Surgery at CCHMC, and Hugo Guterman, professor of electrical and computer engineering at BGU are collaborating on the image guided needle insertion device concept. It combines sophisticated new imaging techniques with the precision of robotics to improve the accuracy of many procedures.

Each project will receive up to $100,000 in the first round, with all funding contingent upon achieving project-specific developmental milestones.

Speaking to the value of early stage investment in research, von Allmen said, “One of the enormous struggles for physicians, many of whom are very experienced in their fields and knowledgeable about challenges to care, is the ability to get an idea from the back of a napkin in the cafeteria to a coordinated development effort. Cincinnati Children’s has put a lot of resources into creating the infrastructure to make the translation of good ideas to products a reality.”

Cincinnati-based seed-stage investor CincyTech and Israel-based Ridgeback Business Development helped evaluate the projects.

Recent Posts

Blog Post Archive

Blog Post Categories

Search the Blog

Newsticker


BioOhio Member Mark BioOhio Member

University of Toledo Medical Center’s new $36M simulator makes training nearly real | Toledo Blade, April 23, 2014

Aerpio Therapeutics closes $22M financing led by OrbiMed (pdf) | Aerpio Therapeutics, April 23, 2014

CTI Clinical Trial & Consulting Services continues to grow with promotions and new hires | Cincinnati.com, April 22, 2014

Austen BioInnovation Institute in Akron presenting two FDA events in one day, April 29 | Austen BioInnovation Institute in Akron, April 22, 2014

OSU collaboration with California’s Oakbio awarded $500k from Canada’s CCEMC to develop biofuels | PR Newswire, April 22, 2014

OSU students’ non-polluting KAir battery wins $100K from US DOE | Columbus Business First, April 22, 2014

The Medical Imaging Technology Partnering Forum part of Cleveland’s medical imaging strength | Cleveland.com, April 22, 2014

Akebia Therapeutics stock rose 55% last week, from below $17 to above $26 | Cincinnati Business Courier, April 21, 2014

The Austen BioInnovation Institute in Akron working with Nottingham Spirk, a Cleveland-based design firm | Akron Beacon Journal, April 21, 2014

CincyTech discusses recent funding for Assurex Health & Sirrus (Bioformix) | Cincinnati Business Courier, April 21, 2014

Akron Children’s joins with Cincinnati Children’s to offer access to new cancer treatments | Akron Beacon Journal, April 20, 2014

OSU Biomedical Engineering students and OncoFilter partners Kinshuk Mitra and Brett Geiger featured on 10TV Columbus | WBNS 10TV Columbus, April 19, 2014

Case Western Reserve University event emphasizes a constellation of research (slideshow) | Cleveland.com, April 19, 2014

Airway Therapeutics granted orphan designation for its product to prevent BPD by European regulatory authority | Cincinnati.com, April 19, 2014

Assurex Health and Sirrus (Bioformix) lead 2014 Q1 funding rounds | Cincinnati.com, April 18, 2014

PhRMA Annual Meeting keynote speakers available on YouTube | PhRMA, April 18, 2014

Alkermes CEO Richard Pops speaks with Xconomy about building the business | Xconomy.com, April 18, 2014

Case Western Reserve University scientists discuss a portable malaria detector (video) | Inside Science TV, April 18, 2014

Ashland University Schar Nursing College starts Doctor of Nursing Program | WMFD Mansfield, April 18, 2014

Kent State Researchers discover new liquid crystal structure | Kent State University, April 17, 2014